Dr Javier Cortés speaks to ecancer about the current COVID-19 pandemic and its effect on breast cancer care.

He emphasises that breast cancer is also a deadly disease in addition to the SARS-CoV-2 virus and these patients should not be forgotten about during the course of this pandemic.

Dr Cortés believes that crucial treatments for HER2-positive and triple-negative metastatic breast cancer should not be delayed. There is currently scarce evidence to suggest that immunotherapy has an adverse effect on patients with COVID-19.

He outlines how patients should be carefully managed during the course of the pandemic.

More videos in this series:

Prof Philip Poortmans (University of Antwerp, Antwerp, Belgium) - Diagnosing, treating and managing breast cancer during COVID-19

Prof Stephen Johnston (Royal Marsden NHS Foundation Trust, London, UK) - COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic

Prof Alessandra Gennari (University Hospital of Novara, Piedmont, Italy) - An oncologist's experience of managing breast cancer during the COVID-19 outbreak

Produced with an educational grant from Eisai Europe Limited who, other than suggesting the topic, were not involved in the review of the videos or the selection of the clinicians in this video.